Validated across a wide range of peer-reviewed publications
We work with forward-looking researchers to demonstrate the clinical value of our solutions to patients, clinicians and the risk-bearing payors such as health plans and accountable care organizations (ACOs) that support them.
Clinical Evidence
Engagement, patient experience and reported outcomes in monitoring severe asthma with initiated biologics
2023
High engagement in remote monitoring with personalized support for people with COPD
2023
High data quality and adherence in remote asthma diagnosis assessment program
2023
High quality of NuvoAir spirometry in children with CF
2022
High adherence rates to daily and weekly spirometry in ILD patients
2022
Clinical effectiveness and validity of NuvoAir home spirometry in children with cystic fibrosis
2022
Real-world study shows Air Next comparable to office spirometry for children with asthma
2022
NuvoAir spirometry FEV1 data predicts asthma exacerbations
2022
AstraZeneca real-world evidence study for a severe asthma treatment uses NuvoAir to monitor and assess lung function
2022
NuvoAir resulted in high adherence, high reliability and high concordance with hospital-based spirometry in Boston Children's Hospital study
2022
Boston Children's Hospital finds high reliability and good concordance to in-clinic testing with children with CF
2022
CF patients and clinicians report time savings with home spirometry
2022
Study in Italy with virtual care with NuvoAir for CF shows reduction in exacerbations
2022
CF patients report improved consultations with providers and understanding of their condition
2022
COPD members are highly engaged when supported by care coordinators in NuvoAir Virtual-First Care
2022
Regeneron observational study used NuvoAir to monitor effects of allergen exposure on asthma patients
2021
Improved clinical outcomes seen with long-term use of the NuvoAir Home platform
2021
Patients and clinicians in England-wide survey report high value and trust with NuvoAir Home to detect changes in lung function and monitor lung health
2021
NuvoAir Cough app shows precision rate of 84% in detecting coughs
2021
Improved attendance rates and reduced hospital admission rates with virtual clinics supported by NuvoAir Home for patients with difficult asthma
2021
Adults with severe asthma perform high quality unsupervised home spirometry with NuvoAir
2021
High acceptability of NuvoAir home monitoring with pediatric asthma patients at Royal Brompton Hospital
2021
Quality and high adherence to NuvoAir Home shows promise for long-term monitoring of pediatric asthma
2021
NuvoAir supports home administration of biologics for pediatric severe asthma
2021
NuvoAir Home respiratory platform supports remote monitoring of asthma patients
2020
Unsupervised home spirometry with the platform is found equivalent to in-clinic spirometry
2020
NuvoAir with unsupervised in-app coaching meets ATS/ERS repeatability criteria for both pediatric CF and bronchiectasis patients
2020
Swedish pilot shows technology can be used at home by children with CF with postive experience of virtual clinics
2020
Proven effective in driving virtual consultations during an 18-month patient research
2020
Pilot Study with Göteborg, Respiratory Medicine confirms NuvoAir Platform well complements CF care
2020
NuvoAir Reduced Booked and Urgent Face to Face Consultations in Cystic Fibrosis Patients
2020
Pilot study with Royal Brompton Hospital suggests NuvoAir platform may improve Cystic Fibrosis outcomes
2019
Validation of the Technology
Pediatric asthma and cystic fibrosis study validates NuvoAir spirometer against conventional spirometry
2020
Validation of Air Next spirometer in patients with different respiratory diseases
2020
200 patient study validates Air Next against Gold standard spirometry
2020
NuvoAir supports 10,000 Families Study for health assessment screening in Minnesota, U.S.
2020
Air Next supports Kazakhstan Academy of Preventive Medicine in assessing lung function changes in a COPD patient population
2020
200 patient study at Tygerberg Academic Hospital, Cape Town, South Africa validates NuvoAir spirometry technology
2019
NuvoAir technology supports 26 300 COPD patient study in Germany
2018
NuvoAir technology chosen for lung function monitoring in ALS study
2018
200 patient study at University Hospital Complex of Vigo, Spain validates NuvoAir spirometry technology
2018
Real-World-Data from our engagements reveals great health economic outcome potential and staggering acceptance
Booked
Consultations
Urgent
Consultations
Improved understanding
of their condition
Improved
medication adherence
ePS1.07 Patient experience of virtual consultations: survey results, Journal of Cystic Fibrosis Volume 19, Supplement 2, June 2020, Page s39
